Cancer-Associated Fibroblast Heterogeneity in Malignancy with Focus on Oral Squamous Cell Carcinoma
International Journal of Molecular Sciences · 21.01.2024 · 25 (2) · 1300
DOI: 10.3390/ijms25021300 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.01.2024. Verfasst von Julia Arebro und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interdisciplinary Oncology, British Columbia Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Cancer-Associated Fibroblasts, Head and Neck Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Swedish Society of Medicine, Royal Swedish Academy of Sciences.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) remains an understudied and significant global cancer killer and dismal survival rates have not changed in decades. A better understanding of the molecular basis of OSCC progression and metastasis is needed to develop new approaches for treating this disease. The supportive network surrounding cancer tumor cells known as the tumor microenvironment (TME) has gained increasing interest lately since it performs essential protumorigenic functions. Cancer-associated fibroblasts (CAFs) are one of the main cell types in the TME and are known to play a key role in influencing the biological behavior of tumors. CAFs present a heterogeneity both in phenotype as well as functions, leading to the suggestion of different CAF subtypes in several cancer forms. The task to subtype CAFs in OSCC has, however, just begun, and there is today no united way of subtyping CAFs in this disease. This review aims to define the features of CAFs and to summarize CAF subtype research in malignancy with focus on OSCC including aspects as disease prognosis and therapeutic opportunities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Interdisciplinary Oncology, British Columbia Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada.
- Division of ENT Diseases, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 14186 Stockholm, Sweden.
- Department of ENT Diseases, Karolinska University Hospital, 14186 Stockholm, Sweden.
- Interdisciplinary Oncology Program, University of British Columbia, Vancouver, BC V5Z 1L3, Canada.
- Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada.
- Division of Otolaryngology, Department of Surgery, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
ORCID-Profile: Che-Min Lee
Förderung
- CIHR
- Swedish Society of Medicine
- Royal Swedish Academy of Sciences
- Sweden-America Foundation
- Lindhés Lawyes Agency
- Karolinska Institutet
- Swedish Association for Otorhinolaryngology Head and Neck Surgery
- Acta Oto-Laryngologica
Zitieren
APA
Arebro, J., Lee, C. M., Bennewith, K. L., & Garnis, C. (2024). Cancer-Associated Fibroblast Heterogeneity in Malignancy with Focus on Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences, 25(2), 1300. https://doi.org/10.3390/ijms25021300
Vancouver
Arebro J, Lee CM, Bennewith KL, Garnis C. Cancer-Associated Fibroblast Heterogeneity in Malignancy with Focus on Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2024;25(2):1300. doi:10.3390/ijms25021300
BibTeX
@article{Arebro2024,
author = {Arebro, Julia and Lee, Che-Min and Bennewith, Kevin L and Garnis, Cathie},
title = {Cancer-Associated Fibroblast Heterogeneity in Malignancy with Focus on Oral Squamous Cell Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {2},
pages = {1300},
doi = {10.3390/ijms25021300}
}
EUVIMED